Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.370
-0.020 (-1.44%)
At close: Jun 2, 2026, 4:00 PM EDT
1.390
+0.020 (1.47%)
After-hours: Jun 2, 2026, 5:59 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $99.05 million as of June 2, 2026. Its market cap has increased by 84.35% in one year.
Market Cap
99.05M
Enterprise Value
57.04M
1-Year Change
84.35%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $99.05M, a decrease of -79.75%. That is a compound annual growth rate of -26.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 100.50M | 14.63% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 106.07M |
| Inovio Pharmaceuticals | 104.88M |
| Outlook Therapeutics | 101.89M |
| PepGen | 101.68M |
| Verrica Pharmaceuticals | 101.35M |
| Cardiff Oncology | 101.19M |
| Aldeyra Therapeutics | 100.13M |
| Rein Therapeutics | 99.55M |